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Abstract
Using viral metagenomics we identified a novel parvovirus species in human stool whose closest
phylogenetic relative is the human bocavirus (HBoV). HBoV2 has an identical genomic organization
to HBoV but share only 78%, 67%, and 80% identity to its NS1, NP1 and VP1/VP2 proteins. Using
PCR we detected HBoV2 sequences in 5/98 Pakistani children stool samples and 3/699 stool samples
from the UK. Near full genome sequencing showed the presence of three divergent genotypes and
evidence of recombination. Further studies are required to determine sites of replication of HBoV2
and potential associations with clinical symptoms or disease.
Introduction
The Parvoviridae family includes the Parvovirinae subfamily infecting vertebrates and the
Densovirinae subfamily infecting insect arthropods. Parvovirinae subfamily members known
to infect humans consist of parvovirus B19 (in the Erythrovirus genus)[1], the apathogenic,
typically helper dependent, human adeno-associated viruses (AAV in the Dependovirus
genus), the human bocavirus (HBoV in the Bocavirus genus) and PARV4 (unassigned genus)
[2,3]. HBoV was discovered in respiratory samples from children [3] but is also found in stool
samples of children with gastroenteritis [4-10]. The association of HBoV with both respiratory
infections and gastroenteritis are highly active areas of research that have been recently
reviewed [11-14]. The pathogenicity of PARV4, detected in blood and tissues, particularly in
injection drug users and HIV infected subjects, remains undetermined [2,15,16].
B19 and PARV4 are found as closely related but distinct genotypes [17-21] and are also
archived in lymphoid tissue for years after primary plasma viremia has resolved [16,22,23].
The observation of distinct genotype distributions of archived B19 and PARV4 in different
age cohorts likely reflects large-scale epidemic sweeps and associated genotype replacements
[16,22-24].
Using non-specific viral particle purification and random nucleic acid amplification combined
with minimal sequencing we identified and sequenced a new human parvovirus related to
HBoV in stool samples of a Pakistani child with acute flaccid paralysis (AFP). We report here
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on its genomic and phylogenetic analysis, along with an initial investigation of its prevalence
and genetic diversity.
Patients, materials, and methods
Stools from 57 children with non-polio AFP (mean age 54.6 months) and 41 from healthy
Pakistani children (mean age 39.8 months) were analyzed. Samples were collected as part of
the WHO poliovirus eradication program. 699 stool samples from a mixed age population
submitted for enteric bacteriology screening in Edinburgh were analyzed.
Stool supernatants were processed for viral metagenomics as previously described [25] with
minor modifications (supplemental methods). The resulting random PCR products derived
from nuclease resistant, viral-sized particles associated RNA and DNA were subcloned and
plasmids inserts sequenced. The resulting sequences were analyzed by tBLASTx against
Genbank database. The viral 5’ and 3’ extremities of HBoV2 were amplified using a
modification of RACE (rapid amplification of cDNA ends) [2].
Conditions for HBoV and HBoV2 PCR are described in supplemental methods.
Sequence distances for different genomic regions were measured using built in functions in
the Simmonics2005 sequence editor v1.6 [26]. Trees were constructed from pairwise
nucleotide and amino acid sequence distances by neighbour-joining in the MEGA2 package.
The robustness of groupings was calculated by bootstrap re-sampling of 1000 replicates of the
data. Genbank accession numbers are: xxxxx. All studies were performed with approval of the
UCSF committee on human research.
Results
Viral-sized particles were first purified from two consecutive stool samples from a Pakistani
child with AFP. Nuclease resistant (i.e. capsid protected) viral nucleic acids were then extracted
and randomly amplified (see Materials and Methods). The resulting random amplification
products were subcloned and 97 plasmid inserts were sequenced and analyzed by tBLASTx.
Exact sequence matches were found in Genbank to human sequences as well as to Micrococcus
luteus, Pseudomonas fluorescens and uncultured bacterium sequences. Highly significant but
imperfect matches (E score <10−10) we also found to Chlamydophila pneumoniae, Rhodoferax
ferrireducens and numerous bacteriophages. A single perfect sequence match was found to
human poliovirus 1 vaccine strain Sabin 1. The detection of a polio Sabin 1 viral sequence
likely reflected ongoing replication of orally administered polio vaccine in this child of 36
months who had previously received a total of 14 oral polio vaccinations.
11/47 plasmid sequences from the first stool sample (plus 19/48 from the second time point)
gave highly significant tBLASTx E scores to the HBoV genome reference sequence
(NC_007455). PCR was then used to link the different HBoV-like fragments while 5’ and 3’
RACE [2] were used to amplify the viral extremities. 5196 bases of a novel bocavirus genome
were assembled. Based on the ST2 prototype genome sequence of HBoV we estimate, that at
least 7 bases are missing from the 5’ end while the genome described here extends for a further
25 bases at the 3’ end. Because the closest genetic relative of this new virus was HBoV we
named it HBoV2.
The arrangement of ORF's in the prototypic HBoV2 genome was similar to that of HBoV, with
three large, coding sequences (Supplemental fig. 1). The 5'NS1 ORF is required for viral DNA
replication and the regulation of viral gene expression. Its protein sequence identity with HBoV
was 78% and was co-linear through the gene. The second ORF, NP1, was 4 amino acid shorter
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and 67% identical. NP1 is a protein of unknown function restricted to bocaviruses [27, 28].
The third large ORF encoded a protein with 80% identity to the VP1/VP2 of HBoV. Relative
to the HBoV coding sequence, the VP1 of HBoV2 was preceded by a 25 amino acids
methionine initiated ORF stretch and a four amino acid deletion downstream resulting in a
slightly larger VP1. Through comparison with HBoV, we predicted the VP2 protein of HBoV2
started at the 154th amino acid of the third large ORF.
To investigate whether widely used PCR assays for HBoV would be able to amplify HBoV2,
we extracted from the literature the PCR primers used for HBoV and aligned them with the
homologous regions of HBoV2 (supplementary Table 1). Most PCR primers contained a
substantial number of mismatches with HBoV2 that would preclude or greatly reduce the
efficiency of amplification and amplicon detection.
To determine the relationship of HBoV2 to other members of the Bocavirus genus,
phylogenetic analyses were performed for the three large ORFs (VP1/2, NP-1 and NS) using
both nucleotide and deduced protein sequences (Fig. 1). The prototype HBoV2 variant
(PK5510), while more closely related to HBoV than the animal bocaviruses, CnMV and
BPV-1, consistently adopted an outlier position to the clade containing all the published HBoV
sequences in all three genomic regions. Reflecting this, pairwise nucleotide distances between
HBoV2 and HBoV were substantially greater (22−26%) than within the HBoV clade (0.4
−0.9%) (Table 1), but less than between HBoV or HBoV2 sequences and animal bocaviruses
(46−56%). Similarly, while almost no amino acid sequence variability was observed among
HBoV sequences in any genomic region (0.2−0.5%), sequences of all three major genes
differed substantially from HBoV2 (20−33%). An unusual partial NS1 HBoV sequence has
been reported in Brazil and adopted an intermediate position between HBoV and HBoV2 on
phylogenetic analysis (Fig. 1 Partial NS1 EF560212 in grey). Interestingly this Brazilian HBoV
sequence was derived from the feces of a child with gastrointestinal symptoms [8].
To determine the prevalence of human bocaviruses we used nested PCR primers specifically
targeting HBoV and HBoV2 NS region. DNA from the stool samples of 57 Pakistani children
with AFP and 41 healthy Pakistani children, plus 699 stool samples submitted for enteric
bacteriology screening in Edinburgh were analyzed. A total of three AFP stool samples
(including the original patient 5510) and two stools from healthy Pakistani children were
positive for HBoV2 DNA sequences (ages were 12, 16, 36, 36, and 96 months). HBoV was
not found among the 57 AFP stools. The stool samples from the UK were tested in pools of
10 samples in which two HBoV (ages 1−2 years and 3−5 years) and three HBoV2 (ages 0−3
months, 6−12 months and >65 years) positive samples were identified.
To investigate the genetic diversity of HBoV2, the partial NS region amplicons from the
Pakistan and UK samples were sequenced and compared to prototypic HBoV2 and other
available human and animal bocavirus sequences (Fig. 1 Partial NS1). Although this initial
survey was small, HBoV2 variants fell into 3 groups or genotypes (gts) (Fig 1 Partial NS1)
showing 4.5% sequence divergence from each other in this region of the bocavirus genome
(Table 2B), a level of diversity much greater than observed between known variants of HBoV
(0.7% in this region). HBoV diversity was more comparable to mean diversity seen within any
of the three HBoV2 genotype (0.9%).
To further investigate HBoV2 diversity, we obtained near complete gnome sequences of
representative of the other two NS1 based genotypes (gt1: HBoV2 prototype PK5510, gt2:
PK2255, and gt3: UK648). Neither HBoV2 variant contained the methionine initiated 25 amino
acid stretch seenupstream of VP1 in PK5510 prototype but had otherwise identical length NS1
and NP1 genes (except from NP1 of PK5510 that was one amino acid shorter). As observed
for HBoV, sequence divergence within HBoV2 was highly conservative, with very low dN/
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dS ratios in all three genome regions (Table 1). Despite the approximately equal degrees of
sequence divergence between the HBoV2 genotypes in the partial region of NS1 initially
sequenced, phylogenetic relationships varied in different genome regions (Fig. 1). The gt1-
PK5510 and gt2-PK2255 variants clustered closely in VP1, with gt3-UK648 as a outlier, while
gt3-UK648 and gt2-PK2255 clustered in the NP1 and NS1 genes with gt1-PK5510 as the
outlier (Fig 1). Using sliding window analysis of pair-wise nucleotide distances over the
HBoV2 genome, gt2-PK2255 and gt3-UK648 showed a lower level of divergence relative to
the other two pair-wise comparisons in the NS1 and NP1 regions (supplementary Fig 2 red
line) while gt1-PK5510 and gt2-PK2255 were nearly identical in the VP1/VP2 region
(supplementary Fig 2 green line). Discordant phylogenies and inconsistent sequence
divergence values between HBoV2 variants is consistent with the occurrence of complex
recombination events in the evolution of these viruses. Putative breakpoints were located near
the middle and 3’ end of NS1 and potentially more recently (ie.recombinants showing a lower
level of divergence) near the beginning of the VP1/VP2.
Discussion
Based on the VIIIth report of the International Committee on Taxonomy of Viruses (ICTV),
different bocavirus species should show NS gene nucleotide sequence similarities below 95%.
HBoV2, showing 75.6% nucleotide similarity to its closest relative HBoV therefore qualifies
as a new human parvovirus and the fourth species in the Bocavirus genus following BPV,
CnMV and HBoV. We believe this terminology is more appropriate than its alternative possible
name as HBoV genotype 2 because genotypes of other parvoviruses, such as those reported
for B19 and PARV4 are much less divergent from each other and do not qualify as separate
species using ICTV guidelines.
HBoV2 divergence also likely precluded its detection using HBoV based PCR (supplementary
Table 1). Thus the extensive epidemiological and clinical information on human bocavirus
collected to date refers exclusively to HBoV, and the available sample archives of clinical
specimens will have to be screened again with HBoV2-specific primers to investigate its
frequency and potential disease associations.
Because parvoviruses are particularly hard to inactivate using heat and detergent treatment
they are of special concern in blood product transfusions and some countries screen for
parvovirus B19 DNA to exclude highly viremic donations from blood derived products
[29-32]. Whether HBoV2 can result in plasma viremia as seen for HBoV and PARV4 [13,
33], will require further studies. The development of serological assays, as recently achieved
for HBoV [13,33], will allow larger epidemiological studies to measure the rate of
seroconversion in different age and geographic cohorts and whether detection of IgM and rise
in IgG titers are associated with particular symptoms.
Three genotypes of HBoV2 were characterized whose genetic distances to one another (in
partial NS1 sequences) were comparable to those measured between B19 or PARV4 genotypes.
The HBoV2 genotype geographic distribution appeared different with all three HBoV2 gt3
being derived from the UK while both genotype 1 and 2 where found in Pakistan.
Recombination events among HBoV2 variants were also observed as recently reported for
animal parvoviruses [34]. The existence of geographic clustering, further genotypes, and
different patterns of recombination will require further screening of samples from a wider
geographical base. If HBoV2 is found archived in tissue as shown for B19 and PARV4 [16,
22-24] the possibility of past epidemic waves of different HBoV2 genotypes will also be
testable using tissues from cohorts of different ages.
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Although the detection of HBoV2 was limited to fecal samples in the current study, its detection
in stools from 5 Pakistani children lends further supports to the gastrointestinal tract as a site
of replication of human bocaviruses [4,7-10]. The detection of HBoV2 in the stool of 3 UK
residents (2 being less then 12 months old and 1 >65 years old) also indicates that this virus is
not restricted to South Asia nor to young children. Whether the lower prevalence of HBoV2
in the UK stools reflect reduced PCR sensitivity due to sample pooling, the older population
tested, reduced virus exposure, or reduced duration or level of enteric viremia remains to be
determined. Further PCR analysis on blood, cerebrospinal and respiratory fluids and stool
samples from symptomatic and matched healthy controls will also be needed establish whether
this virus is associated with respiratory, gastro-intestinal or other symptoms. The equal rate of
detection of HBoV2 in non-polio AFP and healthy Pakistani children (5%) indicates that
HBoV2 is unlikely to be associated with AFP.
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Figure 1. Phylogenetic analysis of Bocaviruses
The 3 major open reading frames were analyzed using both nucleotide and protein sequences
of representative variants of HBoV, HParV5, CnMV (Canine minute virus) and BPV-1 (Bovine
parvovirus-1). Analysis of the partial sequence of NS1 was used to show phylogenetic
relationships of between a larger number of samples amplified by PCR; it also corresponded
to the region of the partially sequenced Brazilian HBoV variant (EF560212).
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